Shionogi has patented antimicrobial compounds, including boronic acid derivatives, for use as therapeutic agents like ß-lactamase inhibitors. The patent covers the compound with the structure of Formula V and its pharmaceutically acceptable salts. GlobalData’s report on Shionogi gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Shionogi, Cancer treatment biomarkers was a key innovation area identified from patents. Shionogi's grant share as of May 2024 was 57%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11999759B2) discloses a compound with a specific chemical structure (Formula V) or its pharmaceutically acceptable salts. The compound can have various substituents such as H, alkyl groups, carbocyclyl, cyclopropyl, and others, as outlined in the claims. Additionally, the patent covers pharmaceutical compositions containing the compound along with a pharmaceutically acceptable excipient and a ß-lactam antibacterial agent for treating bacterial infections, particularly those caused by resistant enterobacteriaceae strains.
Furthermore, the patent describes a method for treating bacterial infections by administering the compound or its salt to a subject in need, especially in cases of infections caused by ß-lactam antibacterial agent-resistant enterobacteriaceae. The method may also involve the separate or combined administration of a ß-lactam antibacterial agent with the compound. Notably, the compound's structure (Formula V) and its variations (Formula Vb, Vc, Vc-1, Vc-2) are highlighted in the claims, emphasizing the potential therapeutic applications in combating bacterial infections, including those caused by Carbapenem-resistant enterobacteriaceae. The patent underscores the significance of these compounds in addressing antibiotic resistance and improving treatment outcomes for such infections.
To know more about GlobalData’s detailed insights on Shionogi, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
